CSIMarket
 


Sage Therapeutics Inc   (SAGE)
Other Ticker:  
 
 

SAGE's Free Cash Flow Growth by Quarter and Year

Sage Therapeutics Inc 's Free Cash Flow results by quarter and year




SAGE Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -126.93 -97.50 1,010.97
III Quarter September -135.87 -118.87 -68.83 -91.02
II Quarter June -131.52 -106.44 -102.77 -118.98
I Quarter March -153.68 -107.80 -109.09 -136.69
FY   -421.07 -460.04 -378.19 664.28



SAGE Free Cash Flow third quarter 2023 Y/Y Growth Comment
Sage Therapeutics Inc in the third quarter 2023 recorded free cash outflow of $ -135.87 millions.

According to the results reported in the third quarter 2023, Sage Therapeutics Inc achieved the best Free Cash Flow growth in Major Pharmaceutical Preparations industry. While Sage Therapeutics Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the third quarter 2023.




SAGE Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Sage Therapeutics Inc 's third quarter 2023 Free Cash Flow $ -135.87 millions SAGE's Income Statement
Sage Therapeutics Inc 's third quarter 2022 Free Cash Flow $ -118.87 millions Quarterly SAGE's Income Statement
New: More SAGE's historic Free Cash Flow Growth >>


SAGE Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Sage Therapeutics Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SAGE's III. Quarter Q/Q Free Cash Flow Comment
Recent free cash outflow of -135.87 millions by Sage Therapeutics Inc look even worse if you take a look at -131.52 millions free cash outflow a quarter before.

Within Major Pharmaceutical Preparations industry Sage Therapeutics Inc achieved highest sequential Free Cash Flow growth. While Sage Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SAGE's III. Quarter Q/Q Free Cash Flow Comment
III. Quarter 2023 accomplishment of -135.87 millions by Sage Therapeutics Inc come out even worse if you take a look at -131.52 millions a quarter before.

Within Major Pharmaceutical Preparations industry Sage Therapeutics Inc achieved highest sequential Free Cash Flow growth. While Sage Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Sage Therapeutics Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Free Cash Flow 12 Months Ending $ -547.05 $ -530.01 $ -504.93 $ -459.10 $ -429.58
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Sage Therapeutics Inc ' has realized cumulative trailing twelve months free cash outflow of $ -547 millions in the Sep 30 2023 period.
The situation is detiriorating as the cumulative free cash outflow is inflating from $ -530.01 millions for the period from Jun 30 2023 to Sep 30 2022 and $ -380.566 millions from the TTM period ending Sep 30 2022 Tom  Wood wrote.

Sage Therapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
Sage Therapeutics Inc ' has realized cumulative trailing twelve months free cash outflow of $ -547 millions in the Sep 30 2023 period.
The situation is getting worse as the cumulative free cash outflow is getting bigger from $ -530.01 millions for the period from Jun 30 2023 to Sep 30 2022 and $ -380.566 millions for the twelve months ending in the quarter a year ago.

Sage Therapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
SAGE's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for SAGE's Competitors
Free Cash Flow Growth for Sage Therapeutics Inc 's Suppliers
Free Cash Flow Growth for SAGE's Customers

You may also want to know
SAGE's Annual Growth Rates SAGE's Profitability Ratios SAGE's Asset Turnover Ratio SAGE's Dividend Growth
SAGE's Roe SAGE's Valuation Ratios SAGE's Financial Strength Ratios SAGE's Dividend Payout Ratio
SAGE's Roa SAGE's Inventory Turnover Ratio SAGE's Growth Rates SAGE's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2023
Lantheus Holdings Inc 24.76%$ 24.764 millions
3m Company24.76%$ 24.755 millions
Select Medical Holdings Corp23.42%$ 23.419 millions
Infusystem Holdings Inc23.38%$ 23.380 millions
Dentsply Sirona Inc 22.94%$ 22.936 millions
Carlisle Companies Incorporated20.98%$ 20.981 millions
Zynex inc 20.00%$ 19.997 millions
U S Physical Therapy Inc19.21%$ 19.210 millions
Addus Homecare Corporation18.94%$ 18.940 millions
Stryker Corp18.11%$ 18.110 millions
Radnet Inc 15.64%$ 15.637 millions
Harmony Biosciences Holdings inc 14.30%$ 14.301 millions
Catalyst Pharmaceuticals Inc 9.27%$ 9.266 millions
Prestige Consumer Healthcare Inc 8.55%$ 8.551 millions
Align Technology inc 7.78%$ 7.777 millions
Mettler toledo International Inc 7.69%$ 7.686 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com